Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer. - Wikidata - awgldk - TriplyDB

Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.

Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.

http://www.wikidata.org/entity/Q36851678

about

Aptamers: A Feasible Technology in Cancer Immunotherapy Aptamers: A promising chemical antibody for cancer therapy Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical science Aptamers: A New Technological Platform in Cancer Immunotherapy Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications Manipulating the in vivo immune response by targeted gene knockdown Aptamer-targeted cell-specific RNA interference Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers Aptamer-targeted antigen delivery.Control of immunity by the TNFR-related molecule OX40 (CD134)Nucleotide bias observed with a short SELEX RNA aptamer library Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction The significance of OX40 and OX40L to T-cell biology and immune disease.Aptamer technology for tracking cells' status & function.Microfluidic chip system for the selection and enrichment of cell binding aptamers DNA Aptamer Assembly as a Vascular Endothelial Growth Factor Receptor Agonist Aptamers for Targeted Drug Delivery Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant.Identification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40.Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy.CD28 aptamers as powerful immune response modulators MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells The role of TNF superfamily members in T-cell function and diseases.The chemical biology of aptamers.Aptamers and aptamer targeted delivery.Nucleic acid based molecular devices.Intracellular delivery of RNA-based therapeutics using aptamers.Aptamers as targeted therapeutics: current potential and challenges.Cell-specific aptamers as emerging therapeutics.Nucleic acid aptamers in cancer research, diagnosis and therapy.Stabilized Interleukin-6 receptor binding RNA aptamers.Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells.Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells.Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers.Bi-specific aptamers mediating tumor cell lysis.OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal.Composite RNA aptamers as functional mimics of proteins.

P2860

Q26740303-5E6113D2-2E33-4BEB-9BFE-9672613D3BF1 Q26766832-B8D996DE-748C-4C25-985A-B65BA3BF6EBB Q26995510-A62617DF-7147-4CCE-8C0C-036766D27592 Q28068981-DF0882FC-2E7A-417C-9A5F-5C825F50CEC2 Q28073119-782CDEF3-AA91-4C73-A796-C868B7719137 Q28083494-F7EE0121-C098-4C4B-B7EF-49A56BC2F13C Q33717239-3F9F2B32-DB40-4349-9107-61AE1B0F6F6A Q33832781-FAA0479E-E4DB-4D75-80ED-BC064D6D7139 Q33870736-C9E23B99-263E-4E99-A25E-716FBE4EDF01 Q33899607-5C59166E-570C-4229-9EA9-0DBF43709826 Q33972934-8645F3C4-78A7-42D7-8179-E9A2F3E7FD25 Q34459418-78A293ED-2D27-4A84-8774-B0E7532E84ED Q34723932-AA8E6F99-6D19-40AB-A809-F9960C506BA1 Q34954124-CE7908A3-71EE-46A6-9976-351B7E395172 Q34979946-03051D1D-CD42-4885-8220-CB0DB9EBBF99 Q35673895-5B3F0737-07E0-43D3-81A6-CD91F245B7AB Q35693283-44778886-8404-472B-A09D-AB93303DDF05 Q36078454-5FE3ECA4-C0CB-4BF7-B362-A1C4DF9DC123 Q36155891-C03AC798-1757-4B3E-BED3-83FA712BB2DF Q36299173-B058C7C0-E19C-407A-80E9-FEF8B63C9CB0 Q36580126-31C8C62B-4AF3-45C8-AC57-987EF8396A3C Q36603032-92A7B026-5479-47A0-86DE-5448B9D3F876 Q36782499-957A7575-0DE6-480E-A785-4CA8A93FF67C Q36968197-4A71234A-1A23-4222-A4B4-E65ADEE2E7A8 Q37268962-24A35566-ED8A-4544-8163-29282D989359 Q37332068-DFC7A12B-5607-4397-961E-2D009397D329 Q37423243-47C1F631-35DC-4E1A-9ED0-AB0DBA9CF3C4 Q37490756-60F1F06E-2A62-4CDF-8485-2DB2BFC84A89 Q37857036-91C4BE82-2BCF-4958-B980-2F8B1936BC5C Q37885186-E7FFD6B8-7D57-4957-BF6A-5045593E0FEF Q38290290-4BB50F64-5891-4B61-B57F-B05F86C3853B Q38302347-66B503A5-2DB3-4D02-9F73-B6AD08D4EAF5 Q38308357-C703FBA1-BD81-4786-99C6-4A000BAFB7FD Q38309627-E871D604-E548-4B3B-AB63-6CC9D6AFAE58 Q38324414-06FF8B27-8AED-428C-9A71-215D27829731 Q38328537-AABD20E1-8534-4313-9612-BE89DE3F8CF6 Q38332777-D0672963-936F-49A4-A106-33CCBD6518BE Q38335529-F84E6322-7FA6-4B00-B495-A646CA5BFA41 Q38374889-09FDAFA8-4EA9-4FAD-A8BC-AB516694AE5D Q38437211-D306A5A3-563F-4678-96AA-C2A9072AE245

P2860

Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.

http://www.wikidata.org/entity/Q36851678

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.

@en

type

label

Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.

@en

prefLabel

Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.

@en

P1433

Q36851678-3FFEDE4F-4D8B-49B5-86D1-903B817920D3

P1476

Q36851678-E3839D7A-602C-4B48-8044-9E7A4A9490BD

P2093

Q36851678-0CEF44F4-EF84-43F2-B6F0-249C5FC6BABA

Q36851678-1394B442-5555-45C4-BE75-2DB550E13A75

Q36851678-A073A8BB-5023-4DE9-AC0E-16F79736BF2E

Q36851678-C12CC064-DAB7-4E73-BFBF-33E12A84F6EF

Q36851678-D9EE6DA3-9B2B-483C-84A4-093159DED80B

Q36851678-F593BBE8-EFF3-4548-A3C6-0D350C78B024

Q36851678-FEF09903-942B-48F1-933A-713F0C5092DB

P2860

Q36851678-03C060A4-D27E-46AC-9129-A5139FE4030B

Q36851678-0810F220-11E0-4E76-A974-95E63C13F839

Q36851678-1B0D4231-A832-4F28-9AC8-74F96D312278

Q36851678-1B3C39CA-C4AD-4AEF-A8E0-FFA93C5DC1AC

Q36851678-2A5CFBA6-D282-4250-9035-4AD9ADCE7A50

Q36851678-2FACC8C7-B131-49B4-B916-F49A0CC646C6

Q36851678-35517354-6D41-4BB4-8AD2-34EF5360AEF6

Q36851678-368C1443-9FE5-4C67-AF14-6F96393F2BCD

Q36851678-403D3E7C-748F-4451-8CB8-C579E28062E5

Q36851678-42E94095-999E-43F8-A2BA-0F08809F6098

P304

Q36851678-7FDC8958-DF67-44DF-BB6A-993E7E81FF06

P31

Q36851678-CAC292C3-5381-482A-BD6E-526EA522E269

P356

Q36851678-299237F8-4ED5-4C49-A52C-6B4B195F5B59

P433

Q36851678-10790A20-DC4A-486E-8E58-411281DD3474

P478

Q36851678-4F0493C5-2F20-4E33-AA64-A5D436A71721

P577

Q36851678-35BEF799-E658-4940-89A1-096325D15104

P5875

Q36851678-ECCAD4C2-610D-4219-BDC1-E2BB60341C75

P698

Q36851678-FAB2C4F8-9C15-4C03-A616-C0B42D031E47

P932

Q36851678-C92796F9-09CD-4C66-A525-9B4EA50B8F36

P356

J.CHEMBIOL.2008.05.016

P1433

Chemistry and Biology

P1476

Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.

@en

P2093

Bruce A Sullenger

http://www.w3.org/2001/XMLSchema#string

Claudia M Dollins

http://www.w3.org/2001/XMLSchema#string

David Boczkowski

http://www.w3.org/2001/XMLSchema#string

Eli Gilboa

http://www.w3.org/2001/XMLSchema#string

Jaewoo Lee

http://www.w3.org/2001/XMLSchema#string

Juliana M Layzer

http://www.w3.org/2001/XMLSchema#string

Smita Nair

http://www.w3.org/2001/XMLSchema#string

P2860

4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

In vitro selection of RNA molecules that bind specific ligands

TNF/TNFR family members in costimulation of T cell responses

Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation

Signalling pathways of the TNF superfamily: a double-edged sword

Direct in vitro selection of a 2'-O-methyl aptamer to VEGF.

Aptamers: an emerging class of therapeutics.

Simultaneous generation of aptamers to multiple gamma-carboxyglutamic acid proteins from a focused aptamer library using DeSELEX and convergent selection.

RNA aptamers as reversible antagonists of coagulation factor IXa.

P304

675-682

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CHEMBIOL.2008.05.016

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51409495

http://www.w3.org/2001/XMLSchema#string

P698

18635004

http://www.w3.org/2001/XMLSchema#string

P932

2525512

http://www.w3.org/2001/XMLSchema#string